USC Norris Comprehensive Cancer Center
An NCI-designated Comprehensive Cancer Center
Senior Leadership
Program Leaders
Genomic and Epigenomic Regulation
The program is led by Woojin An, PhD, who has made breakthrough discoveries on chromatin structure and function, and Yali Dou, PhD, known for translation of epigenetic discoveries into novel inhibitors.
Tumor Microenvironment
The program co-leaders, W. Martin Kast, PhD, and Rongfu Wang, PhD, have complementary recognized expertise in cancer virology & cancer immunology and in immunotherapy, innate immune signaling & epigenetic programming, respectively.
Translational and Clinical Sciences
The program co-leaders, John Carpten, PhD, Parkash Gill, MD, and Heinz-Josef Lenz, MD, have complementary recognized expertise in cancer genomics, drug target discovery, drug development, and translational research and clinical trials.
Cancer Epidemiology
The program co-leaders, Wendy Setiawan, PhD, and Christopher Haiman, ScD, have complementary recognized expertise in cancer epidemiology and genetics, and immunology, biomarkers and biobanking, respectively.
Cancer Control Research
The program co-leaders, Myles Cockburn, PhD, and Jennifer Unger, PhD, have complementary recognized expertise in cancer prevention and cancer survivorship.